A. Rubio

Patterns of kidney dysfunction in acute‐on‐chronic liver failure: Relationship with kidney and patients’ outcome

M. Morales-Ruiz, P. Ginès, G. Crespo, 2022, Hepatology communications.

LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries

H. D. de Koning, F. Lammert, T. Karlsen, 2022, BMC Public Health.

Interaction between metabolic syndrome and alcohol consumption, risk factors of liver fibrosis: A population‐based study

G. Pera, P. Torán, P. Ginès, 2021, Liver international : official journal of the International Association for the Study of the Liver.

Sequential changes in urinary biomarker levels in patients with cirrhosis and severe hepatorenal syndrome

P. Kamath, M. Morales-Ruiz, P. Ginès, 2021, Liver international : official journal of the International Association for the Study of the Liver.

Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosis.

W. Jiménez, M. Morales-Ruiz, P. Ginès, 2021, Journal of hepatology.

LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries

H. D. de Koning, T. Karlsen, G. Pera, 2022, BMC Public Health.

Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study

V. Wong, T. Karlsen, G. Pera, 2023, The Lancet.